在治疗患有脂水的患者中使用Pycnogenol®的影响:随机对照试验
Brenno Augusto S Mello Netto1, José Marcelo Corassa2, Fanilda S Barros3
1Vascular Surgery, Seabra Excelência Vascular, Vitória, BRA.
Cureus
|December 15, 2025
概括
补充Pycnogenol®显著改善了患者的生活质量和减少体脂. 这项研究表明,Pycnogenol®是治疗唇症状的有希望的选择.
科学领域:
- 内分泌学 在内分泌学.
- 营养科学 营养科学
- 医学研究 医学研究
背景情况:
- 脂水是一种慢性,受雌激素影响的疾病,导致女性脂肪沉积异常,往往被误诊.
- 症状包括双边腿部/部脂肪,,疼痛和疼痛,影响生活质量.
- 具有抗氧化特性的聚醇 (Pycnogenol®) 已在慢性静脉功能不充分症中表现出有效性,并用于治疗脂水症状.
研究的目的:
- 为了评估Pycnogenol®在症状控制和体质组合管理中对唇患者的有效性.
- 评估Pycnogenol®对 lipedema 个体的生活质量的影响.
主要方法:
- 一项为期60天,双盲,随机的临床试验,涉及100名唇患者.
- 使用了生活质量调查问卷 (QuASiL),生物阻抗分析和临床监测.
- 由于参与者退出,应用了单调的多重归算来进行数据分析.
主要成果:
- 在60天的时间里,Pycnogenol®组的QuASiL得分显著降低 (p < 0.001),表明症状有所改善.
- 干预组在体重,BMI和身体脂肪百分比方面经历了统计学上显著的减少.
- 而安慰剂组表现出症状恶化,由增加的QuASiL得分表明.
结论:
- 皮cnogenol®显示出作为治疗选择的潜力,用于临床管理脂水.
- 该补充剂有效地减轻与脂质相关的负面身体和情绪影响.
- 进一步的研究支持Pycnogenol®改善唇患者的治疗结果.
相关概念视频
Peripheral Artery Disease III: Interprofessional Care
221
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
221
Atherosclerosis III: Management
293
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
293
Peripheral Artery Disease IV: Nursing Management
316
The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
316


